Anthem Blue Cross and Blue Shield established favorable coverage for Mainstay Medical Holdings’ Reactiv8 restorative neurostimulation for intractable chronic low back pain. Coverage went into effect ...

Anthem Blue Cross and Blue Shield established favorable coverage for Mainstay Medical Holdings’ Reactiv8 restorative neurostimulation for intractable chronic low back pain. Coverage went into effect ...

Recent research indicates that the use of psychedelics has the potential to significantly reduce the experience of chronic ...

Year Follow-Up from a Prospective, Multicenter Study of Percutaneous 60-Day Peripheral Nerve Stimulation for Chronic Low Back ...

Research suggests that better understanding the psychological and neurological components of chronic pain may lead to better ...

Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative Neurostimulation TM therapy ...

Millions of people around the world suffer from chronic low back pain, a condition that often lingers for years and ...

A simple daily spinal mobility routine might just be the answer to those pesky back pains that plague millions. After trying ...

Two oral drugs — o-Vanillin and RG-7112 — cleared zombie cells, reduced back pain and reversed spinal disc damage in mice.

Higher exercise adherence led to greater improvements in pain and functional limitations among adults with chronic low back pain.

Nonbenzodiazepine MRs may improve pain, muscle spasms, and physical outcomes compared with placebo in adults with acute LBP.

A recent preclinical study led by researchers at McGill University has identified two promising drug candidates—o-Vanillin ...